BRCA1/2 Sequencing and Del/Dup analysis
New York
Approved
Genes
Conditions
- Ovarian Cancer
- Breast Cancer
Clinical Utility
- Verification of a genetic basis for cancer in families indicative/suggestive of hereditary breast and ovarian cancer.
- Determination of appropriate screening and treatment.
- Identification of at-risk family members.
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
B362
CPT Codes*
81162x1
ABN Required
No
Turnaround Time**
8-10 days
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing